References
- Geva E, Jaffe RB. 2000. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertility and Sterility 74:429–38.
- Goldsman MP, Pedram A, Dominguez CE, Ciuffardi I, Levin E, Asch R. H. 1995. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertility and Sterility 63:268–72.
- Mizunuma H, Andoh K, Yamada K, Takagi T, Kamijo T, Ibuki Y. 1992. Prediction and prevention of ovarian hyperstimulation by monitoring endogenous luteinizing hormone release during purified follicle-stimulating hormone therapy. Fertility and Sterility 58:46–50.
- Rizk B, Aboulghar M. 1991. Modern management of ovarian hyperstimulation syndrome. Human Reproduction 6:1082–7.
- Vlahos NF, Gregoriou O. 2006. Prevention and management of ovarian hyperstimulation syndrome. Annals of the New York Academy of Sciences 1092:247–64.
- Wang TH, Horng SG, Chang CL, Wu HM, Tsai YJ, Wang HS, Soong, YK. 2002. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. The Journal of Clinical Endocrinology and Metabolism 87:3300–8.
- Worrell GA, Wijdicks EF, Eggers SD, Phan T, Damario MA, Mullany CJ. 2001. Ovarian hyperstimulation syndrome with ischemic stroke due to an intracardiac thrombus. Neurology 57:1342–4.